MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%
INVA — Innoviva, Inc. Common Stock
NasdaqInnoviva, Inc. Common Stock
$20.64
+0.14(+0.68%)
- O
- 20.53
- H
- 20.74
- L
- 20.45
- V
- 872.18K
⏱️ End-of-day dataAs of Oct 5, 2026
Chart
About INVA
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateOct 5, 2004
Employees159
Stock ExchangeNasdaq
Ticker SymbolINVA
Websitehttps://www.inva.com
Key Financial Statistics
| Market Cap | $1.48B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $16.52 - $25.15 |
| 52-Week Avg Volume | 807.5K |
| VWAP | $20.60 |
| Transactions | 12,236 |
| Total Recorded Bars | 5,534 days |